116 related articles for article (PubMed ID: 15978323)
1. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2005 Jul; 225(2):193-8. PubMed ID: 15978323
[TBL] [Abstract][Full Text] [Related]
2. Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
Koyama J; Nisino Y; Morita I; Kobayashi N; Osakai T; Tokuda H
Bioorg Med Chem Lett; 2008 Jul; 18(14):4106-9. PubMed ID: 18556196
[TBL] [Abstract][Full Text] [Related]
3. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives.
Koyama J; Inoue M; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2006 Sep; 241(2):263-7. PubMed ID: 16338070
[TBL] [Abstract][Full Text] [Related]
4. Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of 2-azaanthraquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Hotta H; Takayasu J; Nishino H; Tokuda H
Cancer Lett; 2004 Aug; 212(1):1-6. PubMed ID: 15246555
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
[TBL] [Abstract][Full Text] [Related]
6. Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones.
Koyama J; Morita I; Tagahara K; Osakai T; Hotta H; Yang MX; Mukainaka T; Nishino H; Tokuda H
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1214-6. PubMed ID: 11558617
[TBL] [Abstract][Full Text] [Related]
7. Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of naphthoquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Hotta H; Takayasu J; Nishino H; Tokuda H
Cancer Lett; 2003 Nov; 201(1):25-30. PubMed ID: 14580683
[TBL] [Abstract][Full Text] [Related]
8. Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids.
Koyama J; Morita I; Kobayashi N; Konoshima T; Takasaki M; Osakai T; Tokuda H
Cancer Lett; 2008 May; 263(1):61-6. PubMed ID: 18222035
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation.
Inada A; Nakanishi T; Tokuda H; Nishino H; Iwashima A; Sharma OP
Planta Med; 1995 Dec; 61(6):558-9. PubMed ID: 8824951
[TBL] [Abstract][Full Text] [Related]
10. Studies on the inhibitory effects of some acridone alkaloids on Epstein-Barr virus activation.
Takemura Y; Ju-ichi M; Ito C; Furukawa H; Tokuda H
Planta Med; 1995 Aug; 61(4):366-8. PubMed ID: 7480187
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation.
Koyama J; Morita I; Tagahara K; Ogata M; Mukainaka T; Tokuda H; Nishino H
Cancer Lett; 2001 Sep; 170(1):15-8. PubMed ID: 11448529
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitane glycosides from the fruits of Siraitia gros venorii and their inhibitory effects on Epstein-Barr virus activation.
Akihisa T; Hayakawa Y; Tokuda H; Banno N; Shimizu N; Suzuki T; Kimura Y
J Nat Prod; 2007 May; 70(5):783-8. PubMed ID: 17477572
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein-Barr virus activation.
Tamura S; Fukamiya N; Okano M; Tokuda H; Aoi W; Mukainaka T; Nishino H; Tagahara K; Koike K
Cancer Lett; 2002 Nov; 185(1):47-51. PubMed ID: 12142078
[TBL] [Abstract][Full Text] [Related]
14. Niaziminin, a thiocarbamate from the leaves of Moringa oleifera, holds a strict structural requirement for inhibition of tumor-promoter-induced Epstein-Barr virus activation.
Murakami A; Kitazono Y; Jiwajinda S; Koshimizu K; Ohigashi H
Planta Med; 1998 May; 64(4):319-23. PubMed ID: 9619112
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells].
Zeng Y; Zhou HM; Xu JP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):251-3. PubMed ID: 6295650
[No Abstract] [Full Text] [Related]
16. Sterol ferulates, sterols, and 5-alk(en)ylresorcinols from wheat, rye, and corn bran oils and their inhibitory effects on Epstein-Barr virus activation.
Iwatsuki K; Akihisa T; Tokuda H; Ukiya M; Higashihara H; Mukainaka T; Iizuka M; Hayashi Y; Kimura Y; Nishino H
J Agric Food Chem; 2003 Nov; 51(23):6683-8. PubMed ID: 14582960
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin-induced cutaneous eruption associated with Epstein-Barr virus reactivation.
Saito-Katsuragi M; Asada H; Yokoi S; Niizeki H; Miyagawa S
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S127-8. PubMed ID: 15858511
[No Abstract] [Full Text] [Related]
18. Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products.
Akihisa T; Hamasaki Y; Tokuda H; Ukiya M; Kimura Y; Nishino H
J Nat Prod; 2004 Mar; 67(3):407-10. PubMed ID: 15043419
[TBL] [Abstract][Full Text] [Related]
19. Studies on inhibitors of skin-tumor promotion, I. Inhibitory effects of triterpenes from Euptelea polyandra on Epstein-Barr virus activation.
Konoshima T; Takasaki M; Kozuka M; Tokuda H
J Nat Prod; 1987; 50(6):1167-70. PubMed ID: 2832544
[No Abstract] [Full Text] [Related]
20. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
